Advertisement

The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial

      Highlights

      • 24-mth follow-up of a 12-mth intervention comparing IER vs CER in people with T2DM.
      • HbA1c increased above baseline levels in both groups.
      • Both groups maintained a weight loss of approximately 4 kg.

      Abstract

      Aims

      We investigated the effects of intermittent compared to continuous energy restriction on glycaemic control in patients with type 2 diabetes mellitus.

      Methods

      Adults (N = 137) with type 2 diabetes (mean [SD] HbA1c level, 7.3% (56 mmol/mol) [1.3%] [14.2 mmol/mol]) were randomised to one of two diets for 12 months. The intermittent group (n = 70) followed a 2100–2500 kJ (500–600 kcal) diet 2 non-consecutive days/week and their usual diet for 5 days/week. The continuous group (n = 67) followed a 5000–6300 kJ (1200–1500 kcal) diet for 7 days/week. Follow-up occurred at 24 months, 12 months after the completed intervention. The primary outcome was change in HbA1c and the secondary outcome was weight loss.

      Results

      Intention-to-treat analysis showed an increase in mean [SEM] HbA1c level at 24 months in both the continuous and intermittent groups (0.4% [0.3%] vs 0.1% [0.2%] respectively; P = 0.32) (4.4 [3.3 mmol/mol] vs 1.1 [2.2 mmol/mol]; P = 0.32), with a between-group difference of 0.3% (90% CI, −0.31 to 0.83%) (3.3 mmol/mol [90% CI, −3.2 to 9.1 mmol/mol]) outside the prespecified boundary of ± 0.5% (5.5 mmol/mol), so statistical equivalence was not shown. Weight loss was maintained (P < 0.001) at −3.9 kg [1.1 kg] in both groups at 24 months, with a between-group difference of 0.07 kg (90% CI, −2.5 to 2.6 kg) outside the prespecified boundary of ±2.5 kg. There were no significant differences between groups in body composition, fasting glucose levels, lipid levels, or total medication effect score at 24 months, which remained less than baseline.

      Conclusions

      In this prospective analysis weight loss was maintained but despite this HbA1c increased to above baseline levels in both groups.

      Abbreviations:

      HbA1c (glycated haemoglobin A1c)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. 2017. Brussels, Belgium, International Diabetes Federation. (accessed Nov 19, 2018) <https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html>.

      2. World Health Organization. Global report on diabetes. World Health Organization, 2016. (accessed Nov 19, 2018) <https://www.who.int/diabetes/global-report/en/>.

        • Johnstone A.
        Fasting for weight loss: an effective strategy or latest dieting trend?.
        Int J Obes (Lond). 2015; 39: 727-733
        • Seimon R.V.
        • Roekenes J.A.
        • Zibellini J.
        • Zhu B.
        • Gibson A.A.
        • Hills A.P.
        • et al.
        Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials.
        Mol Cell Endocrinol. 2015; https://doi.org/10.1016/j.mce.2015.09.014
        • Varady K.A.
        Intermittent versus daily calorie restriction: which diet regimen is more effective for weight loss?.
        Obes Rev. 2011; 12: e593-e601https://doi.org/10.1111/j.1467- 789X.2011.00873.x
        • Headland M.
        • Clifton P.M.
        • Carter S.
        • Keogh J.B.
        Weight-loss outcomes: a systematic review and meta-analysis of intermittent energy restriction trials lasting a minimum of 6 months.
        Nutrients. 2016; 8https://doi.org/10.3390/nu8060354
        • Davis C.S.
        • Clarke R.E.
        • Coulter S.N.
        • Rounsefell K.N.
        • Walker R.E.
        • Rauch C.E.
        • et al.
        Intermittent energy restriction and weight loss: a systematic review.
        Eur J Clin Nutr. 2016; 70: 292-299https://doi.org/10.1038/ejcn.2015.195
        • Harvie M.
        • Howell A.
        Potential benefits and harms of intermittent energy restriction and intermittent fasting amongst obese, overweight and normal weight subjects-A narrative review of human and animal evidence.
        Behav Sci (Basel). 2017; 7: 4https://doi.org/10.3390/bs7010004
        • Patterson R.E.
        • Laughlin G.A.
        • LaCroix A.Z.
        • Hartman S.J.
        • Natarajan L.
        • Senger C.M.
        • et al.
        Intermittent fasting and human metabolic health.
        J Acad Nutr Diet. 2015; 115: 1203-1212https://doi.org/10.1016/j.jand.2015.02.018
        • Carter S.
        • Clifton P.M.
        • Keogh J.B.
        The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial.
        Diabetes Res Clin Pract. 2016; 122: 106-112https://doi.org/10.1016/j.diabres.2016.10.010
        • Carter S.
        • Clifton P.M.
        • Keogh J.B.
        Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial.
        JAMA Network Open. 2018; 1: e180756https://doi.org/10.1001/jamanetworkopen.2018.0756
        • Corley B.T.
        • Carroll R.W.
        • Hall R.M.
        • Weatherall M.
        • Parry-Strong A.
        • Krebs J.D.
        Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial.
        Diabet Med. 2018; 35: 588-594https://doi.org/10.1111/dme.13595
        • Arnason T.G.
        • Bowen M.W.
        • Mansell K.D.
        Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study.
        World J Diabetes. 2017; 8: 154-164https://doi.org/10.4239/wjd.v8.i4.154
        • Ash S.
        • Reeves M.M.
        • Yeo S.
        • Morrison G.
        • Carey D.
        • Capra S.
        Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with Type II diabetes: a randomised trial.
        Int J Obes. 2003; 27: 797-802https://doi.org/10.1038/sj.ijo.0802295
      3. CSIRO.CSIRO total wellbeing diet online. (accessed Aug 1, 2014) <https://www.csiro.au/en/Research/Health/CSIRO-diets/CSIRO-Total- Wellbeing-Diet-Online>.

        • Mayer S.B.
        • Jeffreys A.S.
        • Olsen M.K.
        • McDuffie J.R.
        • Feinglos M.N.
        • Yancy Jr, W.S.
        Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes.
        Diabetes Obes Metab. 2014; 16: 90-93https://doi.org/10.1111/dom.12191
        • Ohde S.
        • Deshpande G.A.
        • Yokomichi H.
        • Takahashi O.
        • Fukui T.
        • Yamagata Z.
        HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study.
        Diabetes Res Clin Pract. 2018; 135: 166-171https://doi.org/10.1016/j.diabres.2017.11.013
      4. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853.

      5. U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease. Diabetes 1995;44(11):1249-1258. <https://doi.org/10.2337/diab.44.11.1249>.

        • Wing R.R.
        • Blair E.
        • Marcus M.
        • Epstein L.H.
        • Harvey J.
        Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?.
        Am J Med. 1994; 97: 354-362
        • Look AHEAD Research Group
        • Wing R.R.
        Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
        Arch Intern Med. 2010; 170: 1566-1575https://doi.org/10.1001/archinternmed.2010.334
        • Glenny A.M.
        • O’Meara S.
        • Melville A.
        • Sheldon T.A.
        • Wilson C.
        The treatment and prevention of obesity: a systematic review of the literature.
        Int J Obes Relat Metab Disord. 1997; 21: 715-737
        • Maggio C.
        • Pi-Sunyer F.
        The prevention and treatment of obesity: application to Type 2 diabetes.
        Diabetes Care. 1997; 20: 1744-1766